Global Hematology Diagnostics Market Worth Around $9.54 Billion By 2026: Acumen Research And Consulting

Author: Acumen Research and Consulting

Global Hematology Diagnostics market projected to grow at CAGR around 5.8% over the forecast period and reach around US$ 9.54 Bn in 2026. According to the report, the global hematology diagnostics market will continue to be influenced by a range of macroeconomic and regulatory factors. Growing health concerns, rising number of diseases and continues innovations in wound care and various advantages offered by Hematology Diagnostics such as less pain, optimal moisture level maintenance and quicker wound closure have boosted the growth of the global Hematology Diagnostics market. Global Hematology Diagnostics market can be segmented into product and geography.

Download Report Sample Pages For Better Understanding@

Rise in diagnosis of blood disorders is likely to aid Consumables segment growth

In basis of product, the hematology testing market is fragmented into instruments and consumables. The instruments segment is additionally partitioned into reagents, stains, and others. Consumables segment are foreseen to keep up its dominance over the forecast time frame owing to the growing demand for consumables due to rise in blood disorders and other infectious diseases. Likewise, the early detection of diseases and rising awareness are boosting the growth of the market. The primary factors which has boosted in the global hematology diagnostics market are technological advancements and introduction of new product varieties in the recent years. The growing focus on the effective diagnosis of the rising cases of blood disorders in developing as well as developed economies is escalating the growth of the hematology diagnostics market globally. Studies show that in 2017, nearly 172,910 people in the U.S. alone are affected with blood cancers such as lymphoma, leukemia, or myeloma.

Therefore, the demand for advanced hematology analyzers is growing rapidly across the world. Additionally, almost 1,290,773 individuals are either in the reduction shape or are living with myeloma, lymphoma, or leukemia, in U.S. Expanded alertness and knowledge with respect to these conditions among healthcare professionals and in addition patients have likewise adopted the advanced hematology diagnostics gadgets throughout the years. Aside from this, the expanded reception of purpose of-care-testing strategies, innovative headways prompting increasingly exact outcomes and simple to-utilize gadgets, and the simple accessibility of wide range of tests are likely to drive the hematology diagnostics market. Be that as it may, the market could confront headwinds as low mindfulness among populace in developing economies and the high costs of advanced mechanized instruments. On the other hand, increasing automation and technological advancements are some of the factors that are propelling the growth of the instruments segment. For instance, the advanced instruments provide reliability, good sensitivity, ease of operation, specificity, and safety.


Owing to wide usage blood count segment expected to lead the global market

Blood count held the biggest piece of the pie as far as income in 2017 and is foreseen to extend at a worthwhile CAGR over the forecast time frame. Complete Blood Count (CBC) tests are valuable for general assessment of wellbeing amid routine check-ups. Conditions, such as, allergy, anemia, iron and vitamin deficiencies, and infections, are easily diagnosed through these tests. Irregular CBC test results incite other non-hematological corroborative tests, which may analyze maladies, for example, long-term infections, blood cancers, acute infectious ailments, autoimmune and bone marrow disorders, spleen and liver diseases, and other malignancies. Such wide extent of utilization is foreseen to fuel the market development.

Regional Analysis

North America held the largest market share In 2017.. Key factors, such as always expanding geriatric populace, ideal repayment situation, innovative technological facilities, and presentation of cutting edge innovations for the POC test can be ascribed to this development. Asia Pacific is anticipated to grow at highest CAGR during the forecast period. Growing per capita expenditure and increasing adoption of advanced diagnostic products combined with government activities to enhance medicinal services are anticipated to fuel the regional market development.

Major Players

Vital players active in the global hematology diagnostics market included in the report are Abbott Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Boule Diagnostics, F. Hoffmann-La Roche Ltd., Drew Scientific, Bio-Rad Laboratories, EKF Diagnostics, and Beckman Coulter, Inc. New product innovations, acquisitions and mergers, and collaborations are some of the key approaches adopted by these players to counter the rigid competition.


The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report @

Would like to place an order or any question, please feel free to contact at | +1 407 915 4157